[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Arathy et al., 2020 - Google Patents

Microsponges-a new hope for drug delivery system

Arathy et al., 2020

Document ID
1625567468359870867
Author
Arathy S
Sunil S
Publication year
Publication venue
Journal of Pharmaceutical Sciences and Research

External Links

Snippet

Because of the porous nature it can entrap the poorly soluble drugs and provide targeted drug delivery also.[...] the oral drug delivery through the microsponges is also an unavoidable drug delivery system.[...] of cross-linking between chain monomers, ladders are …
Continue reading at search.proquest.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
CA2805430C (en) Method for preparing microspheres and microspheres produced thereby
US20100291200A1 (en) Formulations for poorly soluble drugs
Masotti et al. Chitosan micro-and nanospheres: fabrication and applications for drug and DNA delivery
JP2003522781A (en) Method for the preparation of microspheres containing colloidal systems
Ueda et al. Optimization of the preparation of loperamide-loaded poly (L-lactide) nanoparticles by high pressure emulsification-solvent evaporation
Cai et al. Sustained release of 5-fluorouracil by incorporation into sodium carboxymethylcellulose sub-micron fibers
JP2003509361A (en) How to get fine particles
CA2836891A1 (en) Method for preparing microparticles with reduced initial burst and microparticles prepared thereby
Ofokansi et al. Formulation and evaluation of glutaraldehyde-crosslinked chitosan microparticles for the delivery of ibuprofen
JP2011512418A (en) Nanoparticle carrier for drug administration and method for producing the same
Hanumanaik et al. Solid lipid nanoparticles: a review
Oo et al. Exploring the effect of glycerol and hydrochloric acid on mesoporous silica synthesis: application in insulin loading
Gavali et al. A Review on Microsphere and it's Application
Arathy et al. Microsponges-a new hope for drug delivery system
Szabo et al. Formulation and stability aspects of nanosized solid drug delivery systems
Bazylińska et al. Influence of pH upon in vitro sustained dye-release from oil-core nanocapsules with multilayer shells
Kulkarni et al. Metformin hydrochloride microparticles for oral controlled release: effect of formulation variables
Xu et al. Preparation of a novel form of gelatin with a three-dimensional ordered macroporous structure to regulate the release of poorly water-soluble drugs
Sah et al. Microsphere Overview
Patel et al. Preformulation challenges: the concept behind the selection, design and preparation of nanoformulations
Sultana et al. An approach for lacidipine loaded gastroretentive formulation prepared by different methods for gastroparesis in diabetic patients
Pilaniya et al. Formulation and evaluation of verapamil hydrochloride loaded solid lipid microparticles
Pasam et al. Evaluation and comparison of the formulations of Amlodipine-loaded bovine serum albumin and egg albumin microspheres
Mahajan et al. Preparation and characterization of meselamine loaded PLGA nanoparticles
Singh et al. DEVELOPMENT AND CHARACTERIZATION OF POLY ([epsilon]-CAPROLACTONE) MICROSPHERES CONTAINING ACETAZOLAMIDE